Acute Opioid Overdosage – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Acute Opioid Overdosage – Drugs In Development, 2024 report and make more profitable business decisions.
Opioids are common treatment strategy for treating pain. Drug abuse is commonly seen with opioids as these are habit forming drugs or by misuse. Opioid overdose occurs when opioid medications are taken in larger quantities irrespective of the prescribed amount. Overdosage stimulates the opiate pathway leading to decreased respiratory function and death. Common causes are prescription error, misuse that can be intentional or unintentional. To overcome these ill effects dosage monitoring is practiced with opiates. Respiratory depression, apnea, miosis, drowsiness, confusion and neuro complications are seen. Physical examination of eye lids, respiratory rate, and lab examinations of presence of opioid in blood from the time of ingestion. Antidote naloxone is a common therapeutic approach in patients diagnosed with opiate overdose. Respiratory support with oxygen and removal of opioid toxins from blood and prevention of infections.
The Acute Opioid Overdosage drugs in development market research report provide comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Opioid Overdosage and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Acute Opioid Overdosage | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 10 molecules, with 10 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Acute Opioid Overdosage therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Acute Opioid Overdosage pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Acute Opioid Overdosage treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Avior Bio IncBexson Biomedical Inc
Clear Scientific LLC
Klaria Pharma Holding AB
Mucodel Pharma LLC
Nasus Pharma Ltd
Orexo AB
Sparian Biosciences Inc
Taho Pharmaceuticals Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Acute Opioid Overdosage reports